American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 259-263 , August 2010

Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?

  • Lance D. Dworkin, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Lance D. Dworkin, MD, Department of Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903
  • ,
  • Timothy Murphy, MD

  • Image Result

    Serum creatinine levels for participants in the ASTRAL (Angioplasty and Stenting for Renal Artery Lesions) trial. Contrary to investigators' expectations, kidney function in this population did not de

    Serum creatinine levels for participants in the ASTRAL (Angioplasty and Stenting for Renal Artery Lesions) trial. Contrary to investigators' expectations, kidney function in this population did not deteriorate overall up to 5 years after randomization.

 Originally published online as doi:10.1053/j.ajkd.2010.04.005 on June 28, 2010.

PII: S0272-6386(10)00726-2

doi: 10.1053/j.ajkd.2010.04.005

American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 259-263 , August 2010